Executive order on prescription drug pricing supports key drug industry efforts to weaken the Medicare negotiation program.

Gov. JB Pritzker supports a proposal that would require pharmacy benefit managers to change how they do business.

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

The Global Prescription Drugs Market is valued at USD 1240.33 Billion in 2024 and is projected to reach a value of USD 2755 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.5% between 2025 ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Trump’s move “actually is a step backward because he is rolling back the steps taken to promote negotiation under Medicare of ...